Across four African nations, a generation of young people living with HIV has demonstrated that the form medicine takes can matter as much as the medicine itself. A UCL-led trial found that eight-weekly injections suppressed the virus far more reliably than daily tablets in adolescents — a population long known to struggle with the quiet, relentless discipline of daily treatment. The results arrive as a kind of proof that better tools exist, even as the systems meant to deliver them remain out of reach for the very communities that need them most.
Eight-weekly HIV injections outperform daily tablets in young people, UCL trial shows
1.6 million adolescents aged 10-19 live with HIV globally; improved treatment adherence through injections could reduce transmission and improve long-term health outcomes for this vulnerable population.